[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.211.82.105. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
June 1, 2011

Antihypertensive Treatment of Patients With Cardiovascular Disease but Without Hypertension

Author Affiliations

Author Affiliations: Department of Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia (Dr LaRiccia) (lariccip@mail.med.upenn.edu); and Biomedical Library, University of Pennsylvania, Philadelphia (Dr Morgan).

JAMA. 2011;305(21):2170-2171. doi:10.1001/jama.2011.705

To the Editor: In a meta-analysis of 25 randomized controlled trials, Ms Thompson and colleagues determined that pharmacological treatment of normotensive and prehypertensive patients for the secondary prevention of CVD events was associated with statistically significant decreases in stroke, congestive heart failure (CHF), composite CVD outcomes, and all-cause mortality.1 Are these statistically significant outcomes clinically significant from a patient's perspective or a public health perspective?

First Page Preview View Large
First page PDF preview
First page PDF preview
×